Über das Unternehmen
- Firmenname (rechtlich): Reyoung Pharmaceutical Co., Ltd
- Internationaler Name: 瑞阳制药股份有限公司 (Reyoung Pharmaceutical Co., Ltd.), Zibo, Shandong, China
- Marke / Handelsname: Reyoung
- Registrierungsland: China
- Adresse: No 1 Ruiyang Road, Yiyuan County , Shandong • Shandong
- Anzahl der Mitarbeiter: Ab 5000
Beschreibung:
Reyoung Pharmaceutical Co., Ltd. is one of the leading manufacturers and distributors of pharmaceutical products, operating 31 workshops that produce ten categories and more than 400 specifications of products including tablets, capsules, granules, sterile APIs, intermediates, small-volume injections, powder for injection, lyophilized powder for injection, suppositories, aerosols, dry powder inhalation, soft capsules and parenteral nutrition. Reyoung has registered its products in more than 80 countries and exported to Asia, the Middle East, South America, Europe, Africa and CIS countries.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
API-HerstellerHersteller
Fertigarzneiformen
ExporteurHerstellerMarketing Authorization Holder
Original-Wirkstoffe
Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern Africa: Algeria, Egypt, Libya, Morocco
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Active Pharmaceutical Ingredients
- Fertigarzneiformen: Amoxicillin Capsule, Vitamin E Softgel Capsules, Omeprazole Sodium for Injeciton, Cefotaxime sodium for injection, Vancomicina for injection, Ampicillin Sodium for Injection, Benzylpenicillin Sodium for Injection, OTC medicines, Sterile injectable medicines
- Original-Wirkstoffe: Piperacillin Sodium & Tazobactam sodium
Unsere Produkte & Dienstleistungen
Certifications
FDA
GMP
ISO
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen